Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Jeffrey T L Smith

Evp & Chief Medical Officer at Zymeworks Inc. (ZYME)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $476K

Reported trades

Filed Stock Type Shares Price Value Since
Jan 12SEC ZYMEZymeworks Inc. Sell 9,31026,708 held (−26%) $22.67 $211K +10.4%
Jan 5SEC ZYMEZymeworks Inc. Sell 10,53818,352 held (−36%) $25.10 $265K -0.3%
  • Sell

    Evp & Chief Medical Officer Jeffrey T L Smith sold $211K of ZYME at $22.67 — cuts the stake by 26%.

  • Sell

    Evp & Chief Medical Officer Jeffrey T L Smith sold $265K of ZYME at $25.10 — cuts the stake by 36%.